Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Arti Shah

Pediatrics Lansing, MI Medical Doctor

NPI 1831113638 CMS profile 173930

3937 Patient Care Way, 101, Lansing, MI 48911

Open in the dashboard

General payments

$2,217

118 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Arti Shah of Lansing, MI is reported in the CMS Open Payments database as having received $2,217 across 118 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $382 20
2024 General $425 19
2023 General $306 16
2022 General $377 20
2021 General $350 19
2020 General $210 13
2019 General $166 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Arti Shah
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Arti Shah were reported at $382. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Arti Shah Pediatrics median Middle half National median
2019 $166 $86 $31–$183 $163
2020 $210 $49 $22–$110 $114
2021 $350 $68 $27–$158 $132
2022 $377 $77 $30–$173 $149
2023 $306 $88 $33–$190 $160
2024 $425 $94 $34–$206 $164
2025 $382 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merck Sharp & Dohme Corporation $376 17 payments
  2. Pfizer Inc. $324 19 payments
  3. Takeda Pharmaceuticals U.S.A., Inc. $197 9 payments
  4. Phadia US Inc. $159 9 payments
  5. Sanofi Pasteur Inc. $105 5 payments
  6. kaleo, Inc. $99 6 payments
  7. GlaxoSmithKline, LLC. $97 5 payments
  8. Tris Pharma Inc $89 5 payments
  9. Neos Therapeutics, LP $79 5 payments
  10. Cranial Technologies, Inc $78 5 payments
  11. Other $613 33 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,192 117 payments
  2. Education $25 1 payment
Products named General payments · program years 2019–2025
  1. GARDASIL 9 $340 15 payments
  2. VAXELIS $301 13 payments
  3. TRUMENBA $290 17 payments
  4. VAXNEUVANCE $238 10 payments
  5. COMIRNATY $229 13 payments
  6. ROTATEQ $219 11 payments
  7. PREVNAR 20 $205 11 payments
  8. ImmunoCAP $159 9 payments
  9. VAQTA $156 7 payments
  10. PENBRAYA $142 8 payments
  11. Other $2,248 119 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

118 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record